Member access

4-Traders Homepage  >  Shares  >  Euronext Paris  >  BIOALLIANCE PHARMA    BIO   FR0010095596

BIOALLIANCE PHARMA (BIO)

746
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Paris
04/16/2014 04/17/2014 04/22/2014 04/23/2014 04/24/2014 Date
7.13(c) 7.18(c) 7.83(c) 8.19(c) 7.68(c) Last
438 638 164 172 586 625 442 402 325 308 Volume
-0.42% +0.70% +9.05% +4.60% -6.23% Change
More quotes
Company
BioAlliance Pharma SA develops and manufactures drugs for the treatment of cancer and its associated pathologies. Its product offerings comprise of Orphan Oncology and Specialty. The Orphan Oncology products include drugs for treatment of primary liver cancer, oral mucositis, metastatic melanoma,... 
More about the company
Chart BIOALLIANCE PHARMA
Duration : Period :
BIOALLIANCE PHARMA Technical Analysis Chart | BIO | FR0010095596 | 4-Traders
Full-screen chart
Financials (€)
Sales 2014 16,7 M
EBIT 2014 0,29 M
Net income 2014 0,29 M
Finance 2014 37,0 M
Yield 2014 -
Sales 2015 -
EBIT 2015 -
Net income 2015 -
Debt 2015 -
Yield 2015 -
PER 2014 156,60
PER 2015 -
Capi. / Sales 2014 7,50x
Capi. / Sales 2015 -
Capitalization 162 M
More Financials
Latest news on BIOALLIANCE PHARMA
2d ago BIOALLIANCE PHARMA : DSMB Recommends Continuation of Phase III Clinical Trial
04/17 BIOALLIANCE PHARMA : Reports DSMB Recommendation to Continue Phase III Clinical ..
04/17 BIOALLIANCE PHARMA : Reports a New Positive DSMB Recommendation to Continue Its ..
04/11DJCar-Sales Growth Slows in China
04/10BIOALLIANCE PHARMA SA : quaterly sales release
04/03 BIOALLIANCE PHARMA : Partners with Penn Pharma on the Industrial Development of ..
04/03 BIOALLIANCE PHARMA : Releases Update on Partnerships for Loramyc/ Oravig
04/02 BIOALLIANCE PHARMA : Teams with Penn Pharma on Industrial Development of Validiv..
03/28 BIOALLIANCE PHARMA : announces participation in the Smallcap Event On April 7th ..
03/23 BIOALLIANCE PHARMA : Inks Licensing Pact with Innocutis Holding to Commercialize..
03/05 BIOALLIANCE PHARMA : Updates Achievements and Reports 2013 Consolidated Financia..
03/04 BIOALLIANCE PHARMA : Supplies Updates on Its Major Achievements and Reports 2013..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
BIOALLIANCE PHARMA : Income Statement Evolution
More Financials
EPS Revisions
BIOALLIANCE PHARMA : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF